Explore our brands

Our brands bring together the industry's most influential leaders and scientific experts, inspiring thought-provoking and insightful content that offers a unique perspective on R&D trends and challenges.
Contact
F&D US 2026 Logo Light

From Candidate to Medicine. Now.

The Long Path to Delivery Will Soon Vanish.

Formulation and Delivery US is where advanced pharmaceutics, delivery science and AI-enabled development converge to take a promising molecule and turn it into a real drug product. Over 600 senior scientists, formulation leaders and technology innovators from pharma, biotech and advanced technology platforms. Two days in San Diego focused on the science that gets candidates to clinic.

What the Program Covers

The full formulation and delivery value chain, from the moment a molecule needs to become a medicine to the point it reaches a patient.

The program is designed so that a formulation scientist, a CMC leader, a delivery technologist and a device developer each find the sessions that speak directly to their work. And then cross into each other's tracks for the sessions that connect them.

F&D Top Section Image-1
F&D Whats New Image-1

What to Expect in 2026?

The program reflects where the field is right now, not where it was five years ago.

Nasal and Inhalation drug formulation and delivery is the subject of a dedicated Day 1 track, featuring a Nose to Brain workshop at the end of the day. A full day of speakers from large pharma, small biotechs, and academia, showcases the current advancements in this area. 

RNA design and delivery gets its own dedicated track on Day 2, reflecting the pace of investment in this modality and the formulation and delivery challenges that still need solving. There is a panel discussion focusing on breaking the bottlenecks for the delivery of RNA.

Two Thought Leadership Panel Discussions anchor the program around the conversations the industry most wants to have. Unlocking AI/ML in Drug Discovery - Overcoming Data Quality and Access Barriers on Day 1 addresses one of the most talked about challenges in pharma right now. Formulating Next-Gen Biotherapeutics: Strategies to Enhance Stability, Quality, and Scalability on Day 2 ties together the discussions happening throughout the two days.

Key Event Highlights

An unmissable journey awaits you: from a high-energy AI & Digitalisation Zone to celebrated keynote speakers and insightful roundtable discussions. Discover the moments that will transform your Formulation & Delivery experience.  

Who is Speaking?

Confirmed speakers from AstraZeneca, Johnson and Johnson Innovative Medicine, Novartis, AbbVie, Roche, Regeneron, Bicycle Therapeutics, Immunocore, Merck, Pfizer, UCB, Silence Therapeutics, Entos Pharmaceuticals and leading academic and research institutions.

Two closed-door sessions run for senior leaders outside the main programme. Brain-Targeted Drug Delivery for Neurodegenerative Therapies on Day 1, and Advancing Oligonucleotide Delivery on Day 2.

Three Day 1 roundtables cover patient-centric drug products, New Approach Methodologies and alternative routes of administration for biologics beyond IV.

Two keynotes frame the programme.

Samir Mitragotri Photo

Samir Mitragotri,
Professor at Harvard University — How Are Innovations Driving the Field of Drug Delivery?

Shalini Andersson Photo

Shalini Andersson,
Vice President of RNA, Gene and Cell Therapy at AstraZeneca — Day 2 keynote.

How it Works

The program runs across three simultaneous tracks on each day, designed so attendees can follow a single scientific thread or move across modalities as the agenda demands.

400 pre-arranged one-to-one meetings are scheduled across both days during morning coffee, lunch and afternoon breaks. Each meeting is confirmed in advance, delegates select who they want to meet from a fully profiled list, and only confirmed acceptances appear in their schedule.

The AI and Digitalisation Zone in the exhibition hall runs live technology demonstrations and short tech talks throughout both days, with scheduled demos during lunch on Day 1 and Day 2. Confirmed Zone companies to be released soon!

The Start-Up Zone on Day 1 & Day 2 gives emerging companies a ten-minute pitch slot on the Start-Up Stage, putting founders and early-stage platforms in front of the same audience as the major pharma and biotech speakers.

 

F&D - How it Works
F&D Laptop Screen Mockup

Discover Your Unmissable Schedule.

Discover everything our event has to offer by exploring the agenda page. There, you’ll find detailed information on every presentation, from inspiring keynote addresses to engaging panel discussions. You can also personalise your experience by saving your favourite sessions and building a tailored agenda that fits your interests and schedule, so you never miss the moments that matter most.

Featured Speakers for Formulation & Drug Delivery US 2026

Ashley Adams
Executive Director,
Recursion
Denise Steckel
Industry Clinical Collaborations Lead,
Genentech
Hongfeng Deng
Vice President, Chemistry | mRNA Center Of Excellent,
Sanofi
Laura Rotolo
Formulation Scientist,
Emory University
Muthiah (Mano) Manoharan
Senior Vice President, Innovation Chemistry & Alnylam Distinguished Scientist,
Alnylam Pharmaceuticals
Thomas Von Erlach
Chief Executive Officer,
Vivtex
Abhijat Vatsyayan
Head of Artificial Intelligence & Innovation,
Taiho Oncology
Adamo Sulpizi
"New Drug Delivery & Projects" Unit Manager,
Chiesi
Anil Gupta
Director,
Calibr-Skaggs Institute for Innovative Medicines
Ashley Buckle
CTO & Cofounder,
Scudo Biosciences
Craig Behnke
EVP Production,
Lumen Bioscience
Dan Hardy
CEO,
Microsol
Ed Addison
Professor Of The Practice,
North Carolina State University
Elisabeth Kersten
Formulation Development Leader,
Vividion
Gian Luca Araldi
Chief Executive Officer,
Avanti Biosciences, Inc.
Hima Bindu Gottam
Director,
University of Iowa
Hyunhong James Min
Senior Scientist,
Pfizer Ltd
Isabelle Naëije, PMP
Clinical Operations Learning Manager (Program & Study),
Novartis
Jian Zhou
Scientist,
Novo Nordisk
Jitendra Kumar
Lead Scientist ,
Entos Pharmaceuticals
Kanika Sarpal
Senior Scientist,
Sanofi
Lenora Dieyi
Modeling & Simulation Engineer - Investigator, Drug Product Development,
GSK
Margaret Braunreuther
Senior Scientist I,
AbbVie
Mark Eccleston
Chief Executive Officer,
ValiRx
Navpreet Kaur
Principal Scientist,
Sanofi US Services Inc
Pin-Kuang Lai
Assistant Professor,
Stevens Institute of Technology
Ping Wee
Lead,
Entos Pharmaceuticals
Pranav Mathur
Director and Head (Research and Development),
Cirsium Biosciences
Raj Thakur
Professor in Pharmaceutics & Founder and CTO,
Queens Univeristy Belfast & Re-Vana Therapeutics
Ramesh Dasari
Associate Director,
Sanofi
Ryan Kole
CEO & Co-Founder,
BBT
Sandeep Yadav
Vice President, Technical Development,
Sangamo Therapeutics, Inc.
Santosh Kesarpu
Associate Director, Formulation Research & Development,
Granules Pharmaceuticals Inc
Sarah Altinoglu
Principal Scientist,
Vertex
Sayoni Ray
Principal Scientist,
Johnson & Johnson
Sean Sullivan
Vice President,
Arcturus Therapeutics
Shital Mehta
Principal Scientist,
Vividion Therapeutics
Sinan Golhan
Chief Executive Officer,
GelTech
Sonia Gutierrez Sanfeliciano
Director of Research Computational Chemistry,
Eli Lilly
Tao Wang
Senior Manager,
GSK
Trevor Smith
Vice President,
Inovio
Tuhin Das
Adjunct Professor,
Temple University
Tushar Apsunde
Principal Research Scientist II (Team Lead),
AbbVie
Umar Maharoof
Senior Director, Head of CMC,
Neuraly
Vivek Gupta
Associate Professor and Scientific Founder,
St. John University
Zhihong Huang
Director,
Novartis

San Diego, CA. 12 - 13 October 2026.